Henry Schein raises full-year guidance
The company reports strong Q2 2026 results with 4.6% local currency sales growth and increased margins, driven by dental merchandise strength and technology adoption.
See the latest news and media coverage for Henry Schein. We track all announcements, press releases, and industry mentions in real time, all in one place.
Healthcare products and services distributor
henryschein.comLast updated
In short: Henry Schein delivered strong results, raised 2026 guidance, and completed major leadership changes.
The company reports strong Q2 2026 results with 4.6% local currency sales growth and increased margins, driven by dental merchandise strength and technology adoption.
Second-quarter non-GAAP diluted EPS rose to $1.27 from $1.10, with total net sales increasing 6.7% year-over-year to $3.5 billion.
Total sales grew 6.3% and diluted EPS reached $1.32. The company reaffirmed FY2026 guidance with mid-single digit Adjusted EBITDA growth expectations.
Fourth-quarter sales grew 7.7%, with EPS reaching $1.34 on a non-GAAP basis. The company provided full-year 2026 diluted EPS guidance between $5.23 and $5.37.
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, today reported financial results for the second...
The health care products maker posted revenue of $3.46 billion in the period, also exceeding Street forecasts. Seven analysts surveyed by Zacks expected $3.36 billion...
While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business...
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 22,000...
Track Henry Schein and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Henry Schein and other trending companies.